BIO Stock Overview
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
BIOTON S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł3.50 |
| 52 Week High | zł4.10 |
| 52 Week Low | zł3.30 |
| Beta | 0.16 |
| 1 Month Change | -2.64% |
| 3 Month Change | -0.43% |
| 1 Year Change | -0.99% |
| 3 Year Change | -39.34% |
| 5 Year Change | -24.57% |
| Change since IPO | -97.15% |
Recent News & Updates
Shareholder Returns
| BIO | PL Biotechs | PL Market | |
|---|---|---|---|
| 7D | -1.1% | 1.9% | -1.2% |
| 1Y | -1.0% | -16.4% | 24.4% |
Return vs Industry: BIO exceeded the Polish Biotechs industry which returned -17.2% over the past year.
Return vs Market: BIO underperformed the Polish Market which returned 24% over the past year.
Price Volatility
| BIO volatility | |
|---|---|
| BIO Average Weekly Movement | 1.9% |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 9.6% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: BIO has not had significant price volatility in the past 3 months.
Volatility Over Time: BIO's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 357 | Jeremy Launders | www.bioton.pl |
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
BIOTON S.A. Fundamentals Summary
| BIO fundamental statistics | |
|---|---|
| Market cap | zł300.52m |
| Earnings (TTM) | zł2.28m |
| Revenue (TTM) | zł181.64m |
132.1x
P/E Ratio1.7x
P/S RatioIs BIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIO income statement (TTM) | |
|---|---|
| Revenue | zł181.64m |
| Cost of Revenue | zł108.78m |
| Gross Profit | zł72.85m |
| Other Expenses | zł70.58m |
| Earnings | zł2.28m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 0.026 |
| Gross Margin | 40.11% |
| Net Profit Margin | 1.25% |
| Debt/Equity Ratio | 9.0% |
How did BIO perform over the long term?
See historical performance and comparison